These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 30346051

  • 1. Schisandrin B attenuates epidural fibrosis in postlaminectomy rats by inhibiting proliferation and extracellular matrix production of fibroblasts.
    Jin H, Wang Z, Gu Z, Wu J, Bai X, Shao Z, Miao J, Wang Q, Wang Q, Wang X.
    Phytother Res; 2019 Jan; 33(1):107-116. PubMed ID: 30346051
    [Abstract] [Full Text] [Related]

  • 2. Honokiol protects against epidural fibrosis by inhibiting fibroblast proliferation and extracellular matrix overproduction in rats post‑laminectomy.
    Xu D, Zeng W, Han X, Qian T, Sun J, Qi F, Liu C, Wang Q, Jin H.
    Int J Mol Med; 2020 Dec; 46(6):2057-2068. PubMed ID: 33125121
    [Abstract] [Full Text] [Related]

  • 3. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways.
    Chen Q, Zhang H, Cao Y, Li Y, Sun S, Zhang J, Zhang G.
    Drug Des Devel Ther; 2017 Dec; 11():2179-2191. PubMed ID: 28794616
    [Abstract] [Full Text] [Related]

  • 4. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
    Wu J, Jia J, Liu L, Yang F, Fan Y, Zhang S, Yan D, Bu R, Li G, Gao Y, Chen Y.
    J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
    [Abstract] [Full Text] [Related]

  • 5. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
    Zhang D, Liu B, Cao B, Wei F, Yu X, Li GF, Chen H, Wei LQ, Wang PL.
    Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
    [Abstract] [Full Text] [Related]

  • 6. Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.
    Zhuang W, Li Z, Dong X, Zhao N, Liu Y, Wang C, Chen J.
    Exp Lung Res; 2019 Jul; 45(5-6):157-166. PubMed ID: 31268360
    [Abstract] [Full Text] [Related]

  • 7. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing.
    Zhang H, Chen Q, Dahan A, Xue J, Wei L, Tan W, Zhang G.
    Chem Biol Interact; 2019 Aug 25; 309():108675. PubMed ID: 31150632
    [Abstract] [Full Text] [Related]

  • 8. [Effect of schisandrin B on lung mRNA expression of transforming growth factor-beta1 signal transduction molecule in rat lungs exposed to silica].
    Fan LH, Liu TF, Guo M, Liu ML, Wang ZP, Si SJ.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Apr 25; 29(4):255-9. PubMed ID: 21941776
    [Abstract] [Full Text] [Related]

  • 9. Schisandrin B protects against solar irradiation-induced oxidative injury in BJ human fibroblasts.
    Chiu PY, Lam PY, Yan CW, Ko KM.
    Fitoterapia; 2011 Jun 25; 82(4):682-91. PubMed ID: 21356279
    [Abstract] [Full Text] [Related]

  • 10. Schisandrin B protects against solar irradiation-induced oxidative stress in rat skin tissue.
    Lam PY, Yan CW, Chiu PY, Leung HY, Ko KM.
    Fitoterapia; 2011 Apr 25; 82(3):393-400. PubMed ID: 21111034
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.
    Zhu S, Wang Y, Chen M, Jin J, Qiu Y, Huang M, Huang Z.
    Am J Chin Med; 2012 Apr 25; 40(3):551-66. PubMed ID: 22745070
    [Abstract] [Full Text] [Related]

  • 12. Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway.
    Cuiqiong W, Chao X, Xinling F, Yinyan J.
    Artif Cells Nanomed Biotechnol; 2020 Dec 25; 48(1):473-478. PubMed ID: 31975615
    [Abstract] [Full Text] [Related]

  • 13. Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through the wingless/integrase-1 signaling pathway.
    Wang Y, Dong X, Zhao N, Su X, Wang Y, Li Y, Wen M, Li Z, Wang C, Chen J, Zhuang W.
    Exp Lung Res; 2020 Dec 25; 46(6):185-194. PubMed ID: 32362157
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis.
    Xu M, Zhao C, Song H, Wang C, Li H, Qiu X, Jing H, Zhuang W.
    Sci Rep; 2023 Aug 18; 13(1):13475. PubMed ID: 37596361
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
    Guo M, An F, Yu H, Wei X, Hong M, Lu Y.
    Biomed Pharmacother; 2017 Dec 18; 96():129-136. PubMed ID: 28972885
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction.
    Chen P, Pang S, Yang N, Meng H, Liu J, Zhou N, Zhang M, Xu Z, Gao W, Chen B, Tao Z, Wang L, Yang Z.
    PLoS One; 2013 Dec 18; 8(11):e79418. PubMed ID: 24260217
    [Abstract] [Full Text] [Related]

  • 17. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
    Shao M, Yang W, Han G.
    Int J Nanomedicine; 2017 Dec 18; 12():7121-7130. PubMed ID: 29026305
    [Abstract] [Full Text] [Related]

  • 18. Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification.
    Wu Z, Jia M, Zhao W, Huang X, Yang X, Chen D, Qiaolongbatu X, Li X, Wu J, Qian F, Lou Y, Fan G.
    J Ethnopharmacol; 2022 May 10; 289():115031. PubMed ID: 35091014
    [Abstract] [Full Text] [Related]

  • 19. Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1α/VEGF pathway.
    Chen X, Liu C, Deng J, Xia T, Zhang X, Xue S, Song MK, Olatunji OJ.
    J Pharm Pharmacol; 2024 Jun 06; 76(6):681-690. PubMed ID: 38422325
    [Abstract] [Full Text] [Related]

  • 20. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.
    Dai X, Yin C, Guo G, Zhang Y, Zhao C, Qian J, Wang O, Zhang X, Liang G.
    Toxicol Appl Pharmacol; 2018 Nov 01; 358():110-119. PubMed ID: 30195018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.